Debt-to-equity of Lexaria Bioscience Corp. from 30 Apr 2012 to 30 Nov 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Lexaria Bioscience Corp. quarterly Debt-to-equity in % history and change rate from 30 Apr 2012 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Debt-to-equity for the quarter ending 30 Nov 2025 was 32%, a 429% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 32% +26% +429% 30 Nov 2025
Q3 2025 21% +15% +215% 31 Aug 2025
Q2 2025 17% +12% +246% 31 May 2025
Q1 2025 11% -0.82% -7% 28 Feb 2025
Q4 2024 6% -6.8% -53% 30 Nov 2024
Q3 2024 6.8% -4.5% -40% 31 Aug 2024
Q2 2024 4.8% -3.2% -40% 31 May 2024
Q1 2024 12% +8.4% +255% 29 Feb 2024
Q4 2023 13% +10% +394% 30 Nov 2023
Q3 2023 11% +9% +400% 31 Aug 2023
Q2 2023 8.1% +6.1% +303% 31 May 2023
Q1 2023 3.3% +1.2% +58% 28 Feb 2023
Q4 2022 2.6% -0.04% -1.5% 30 Nov 2022
Q3 2022 2.3% -1.3% -36% 31 Aug 2022
Q2 2022 2% -3.5% -64% 31 May 2022
Q1 2022 2.1% -4.6% -69% 28 Feb 2022
Q4 2021 2.6% -6.7% -72% 30 Nov 2021
Q3 2021 3.6% -2.9% -45% 31 Aug 2021
Q2 2021 5.5% +0.65% +13% 31 May 2021
Q1 2021 6.7% +1.8% +36% 28 Feb 2021
Q4 2020 9.4% +1.6% +21% 30 Nov 2020
Q3 2020 6.4% -0.83% -11% 31 Aug 2020
Q2 2020 4.9% -1.4% -22% 31 May 2020
Q1 2020 4.9% -1.2% -19% 29 Feb 2020
Q4 2019 7.8% +5% +177% 30 Nov 2019
Q3 2019 7.3% +4.5% +165% 31 Aug 2019
Q2 2019 6.2% +3.1% +101% 31 May 2019
Q1 2019 6.1% +3% +100% 28 Feb 2019
Q4 2018 2.8% -4.3% -61% 30 Nov 2018
Q3 2018 2.8% -11% -81% 31 Aug 2018
Q2 2018 3.1% -26% -89% 31 May 2018
Q1 2018 3% -90% -97% 28 Feb 2018
Q4 2017 7.1% -106% -94% 30 Nov 2017
Q3 2017 14% -104% -88% 31 Aug 2017
Q2 2017 29% -26% -47% 31 May 2017
Q1 2017 93% +71% +325% 28 Feb 2017
Q4 2016 113% 30 Nov 2016
Q3 2016 118% 31 Aug 2016
Q2 2016 55% 31 May 2016
Q1 2016 22% 29 Feb 2016
Q3 2014 41% -27% -39% 31 Aug 2014
Q2 2014 45% -24% -35% 31 Jul 2014
Q1 2014 55% -17% -23% 30 Apr 2014
Q4 2013 70% -4.8% -6.5% 31 Jan 2014
Q3 2013 68% -4.9% -6.7% 31 Oct 2013
Q2 2013 69% -1.4% -1.9% 31 Jul 2013
Q1 2013 72% +5.1% +7.6% 30 Apr 2013
Q4 2012 75% 31 Jan 2013
Q3 2012 73% 31 Oct 2012
Q2 2012 71% 31 Jul 2012
Q1 2012 67% 30 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.